Pharmaceutical Executive August 8, 2024
Miranda Schmalfuhs

In this part of his Pharmaceutical Executive video interview, Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma’s US affiliate, discusses how is LEO Pharma positioning itself to capitalize on the unmet needs, patient centric initiatives, and more.

Given the increasing focus of large pharma companies on specific therapeutic areas, how is LEO Pharma positioning itself to capitalize on the unmet needs in other areas, and what strategies are you employing to ensure long-term success in these spaces?

So large pharma companies typically focus on large brands. You know, typically, they’re in the game of trying to find blockbusters, defined by more than a billion dollars in annual sales. And what we’re doing is really focusing in on one...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Pharma, Pharma / Biotech, Trends
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
Key Trends in the Evolution of PBMs and Their Future Impact on Drug Pricing and Pharmacy Operations

Share This Article